(Q33362194)

English

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma

scientific article

Statements

Phase II study of ISIS 3521, an antisense oligodeoxynucleotide to protein kinase C alpha, in patients with previously treated low-grade non-Hodgkin's lymphoma (English)
1 September 2004
1413-1418

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit